Research and Funding

NCCAM participates in comparative effectiveness RFA

September 4, 2012


Participation of NCCAM in RFA-AG-13-003: Secondary Analyses of Comparative Effectiveness, Health Outcomes and Costs in Persons with Multiple Chronic Conditions (R21)
(NOT-AT-13-001)
National Center for Complementary and Alternative Medicine

The purpose of this Notice is to inform applicants that the NCCAM will participate, effective immediately, in the following NIH Funding Opportunity Announcement (FOA):

RFA-AG-13-003: Secondary Analyses of Comparative Effectiveness, Health Outcomes and Costs in Persons with Multiple Chronic Conditions (R21). For this FOA, the following goals are of interest to NCCAM:

  • To assess the public health and health cost impact of complementary health approaches in individuals with two or more conditions,
  • To identify potential differences in effectiveness and safety of different complementary or integrative treatment regimens for patients with specific combinations of two or more conditions,
  • To examine alterations in safety or effectiveness of a complementary or integrative treatment for one condition related to the presence of one or more specific coexisting condition.

NCCAM is interested in meritorious applications responsive to this FOA that fall within its scientific mission. NCCAM intends to commit up to $400,000 total costs in FY 2013. We encourage applications to conduct secondary analyses in datasets that have collected information on the use of complementary or integrative health approaches in individuals with multiple chronic conditions. We are also interested in applications that assess the impact or outcome of utilization of complementary or integrative health approaches.  To facilitate secondary data analyses, NCCAM has posted a list datasets (PDF, 89K) that contain this information.

Examples of specific research questions or projects of interest to NCCAM include but are not limited to:

  • Evaluation of the impact of specific forms of complementary health care utilization on health outcomes or quality of life in individuals living with HIV or AIDS in addition to at least one other condition (e.g. pain, insomnia, etc).
  • Studies assessing the effect of complementary or integrative medicine use in individuals with chronic pain and sleep difficulties.
  • Examination of whether utilization of complementary or integrative approaches in patients with chronic pain and another health condition impacts utilization of pain medications.

All other aspects of this FOA remain unchanged.

Share this:
Email Twitter Linkedin Facebook